Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

Ivermectin exerts over TWELVE distinct anti-cancer mechanisms across more than TWELVE cancer types — according to HUNDREDS of studies. And finally, the NIH has officially acknowledged this and launched studies on ivermectin’s ability to eliminate cancer cells.

Nicolas Hulscher, MPH

264,143 subscribers

245,288 görüntüleme • 6 ay önce •via X (Twitter)

Sağlık & İyilik Bilim & Teknoloji

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.

Nicolas Hulscher, MPH

138,449 görüntüleme • 1 ay önce

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.

HUNDREDS of studies show ivermectin exerts over 12 distinct anti-cancer mechanisms across more than 12 cancer types. That's why COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being published in the peer-reviewed literature. It's also SAFER than Tylenol.

Joe Tippens

15,391 görüntüleme • 1 ay önce

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.

🚨COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature. HUNDREDS of studies find ivermectin and fenbendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

5,203,743 görüntüleme • 4 ay önce

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

1,052,068 görüntüleme • 3 ay önce

We are about to publish the LARGEST human ivermectin-cancer study ever conducted. After 6 months, many patients reported their cancer was GONE. HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types.

We are about to publish the LARGEST human ivermectin-cancer study ever conducted. After 6 months, many patients reported their cancer was GONE. HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

1,692,247 görüntüleme • 4 ay önce

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

Valerie Anne Smith

30,754 görüntüleme • 3 ay önce

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.

🚨The CIA buried knowledge of the anti-cancer effects of anti-parasitics for over 50 YEARS. We now know that ivermectin exerts over 12 distinct anti-cancer mechanisms across 12 cancer types — while COMPLETE REMISSION of Stage IV cancers using fenbendazole has been documented. This vital line of cancer research was set back more than HALF A CENTURY — and millions of cancer victims have paid the price.

Nicolas Hulscher, MPH

22,556 görüntüleme • 5 ay önce

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️

Catturd ™

252,551 görüntüleme • 2 ay önce

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith

This should be front-page news EVERYWHERE. The LARGEST real-world study of ivermectin + mebendazole in cancer patients found that nearly HALF declared CANCER DISAPPEARANCE or TUMOR SHRINKAGE after just 6 months. 84.4% experienced clinical benefit. This was not surprising, as HUNDREDS of preclinical studies have shown anti-parasitics attack tumors via 12 distinct mechanisms across more than 12 cancer types. Brad Smith

Nicolas Hulscher, MPH

19,219 görüntüleme • 4 ay önce

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Follow me.

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Follow me.

Joe Tippens

18,133 görüntüleme • 3 ay önce

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Join the Fight: Courtesy of The Lance Wallnau Show Lance Wallnau #MedicalFreedom

McCullough Foundation

194,700 görüntüleme • 3 ay önce

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 görüntüleme • 1 yıl önce

Studies have shown that certain electromagnetic frequencies, particularly in the low-range (100 to 300 Hz), may have the potential to disrupt cancer cell function and induce cell death, or apoptosis. Research suggests that these frequencies can interfere with cellular mechanisms by affecting ion channels and membrane potentials, disrupting cancer cells' ability to replicate and survive. One notable frequency, 100 Hz, has been explored in preclinical studies, where it was found to selectively impair cancer cells without significantly damaging healthy tissues. However, more clinical studies are required to validate the therapeutic potential of frequency-based treatments for cancer.

Studies have shown that certain electromagnetic frequencies, particularly in the low-range (100 to 300 Hz), may have the potential to disrupt cancer cell function and induce cell death, or apoptosis. Research suggests that these frequencies can interfere with cellular mechanisms by affecting ion channels and membrane potentials, disrupting cancer cells' ability to replicate and survive. One notable frequency, 100 Hz, has been explored in preclinical studies, where it was found to selectively impair cancer cells without significantly damaging healthy tissues. However, more clinical studies are required to validate the therapeutic potential of frequency-based treatments for cancer.

Barbara Oneill

114,837 görüntüleme • 1 yıl önce

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 görüntüleme • 2 ay önce

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 görüntüleme • 2 ay önce

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy

Commentary | Global Ivermectin Research Hub

2,324,509 görüntüleme • 9 ay önce

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

The LARGEST systematic review study ever conducted on ivermectin use in cancer patients identified 14 distinct anticancer mechanisms across 12 cancer types and found no safety concerns. Meanwhile, a recent study reported COMPLETE REMISSION of Stage IV cancers with fenbendazole.

Nicolas Hulscher, MPH

90,205 görüntüleme • 6 ay önce

Anti-Parasitic. Anti-Viral. Anti-Cancer. Two Drugs Already in Your Pharmacy. Ivermectin and mebendazole were developed to fight parasites. Then studies found they also had antiviral properties. Now a patient-reported outcomes study shows anti-cancer effects across nearly 200 patients. The same mechanisms that starve parasites — cutting off proliferation, blocking blood supply, triggering cell death — work on cancer cells too. The science was there. Nobody funded the trials. Join the Fight: Courtesy of The Amber May Show #MedicalFreedom

Anti-Parasitic. Anti-Viral. Anti-Cancer. Two Drugs Already in Your Pharmacy. Ivermectin and mebendazole were developed to fight parasites. Then studies found they also had antiviral properties. Now a patient-reported outcomes study shows anti-cancer effects across nearly 200 patients. The same mechanisms that starve parasites — cutting off proliferation, blocking blood supply, triggering cell death — work on cancer cells too. The science was there. Nobody funded the trials. Join the Fight: Courtesy of The Amber May Show #MedicalFreedom

McCullough Foundation

31,580 görüntüleme • 3 ay önce

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

1. "Ivermectin: A Supercharged Cancer Fighter" Ivermectin is proving to be up to 7 times more effective than conventional treatments in disrupting cancer’s survival mechanisms. With just a single dose, it strikes cancer cells through multiple pathways and helps block the formation of new tumors, both at the original site and in areas where cancer might spread. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

78,082 görüntüleme • 8 ay önce

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom

Cancer Cells and Parasites Feed the Same Way. That's Why This Drug Combination Works. Both drain energy from the host using similar biological mechanisms. Ivermectin and mebendazole — developed to fight parasites — disrupt that process in cancer cells too. They reduce proliferation, cut off the blood supply tumors try to build, and accelerate the packaging and termination of cancer cells. Over 100 pre-clinical studies confirm it. The human data just confirmed it at scale. Join the Fight: Courtesy of Real America's Voice Real America's Voice (RAV), The Steve Gruber Show Steve Gruber #MedicalFreedom

McCullough Foundation

15,960 görüntüleme • 3 ay önce